JP2012525121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012525121A5 JP2012525121A5 JP2012507624A JP2012507624A JP2012525121A5 JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5 JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- tumor
- associated antigen
- antibody
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17387109P | 2009-04-29 | 2009-04-29 | |
| US61/173,871 | 2009-04-29 | ||
| EP09005931A EP2249159A1 (en) | 2009-04-29 | 2009-04-29 | Identification of tumor-associated markers for diagnosis and therapy |
| EP09005931.2 | 2009-04-29 | ||
| PCT/EP2010/002490 WO2010124812A2 (en) | 2009-04-29 | 2010-04-22 | Identification of tumor-associated markers for diagnosis and therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012525121A JP2012525121A (ja) | 2012-10-22 |
| JP2012525121A5 true JP2012525121A5 (enExample) | 2013-05-30 |
Family
ID=41100608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507624A Pending JP2012525121A (ja) | 2009-04-29 | 2010-04-22 | 診断および治療のための腫瘍関連マーカーの同定 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120070430A1 (enExample) |
| EP (2) | EP2249159A1 (enExample) |
| JP (1) | JP2012525121A (enExample) |
| AU (1) | AU2010243863A1 (enExample) |
| CA (1) | CA2760395A1 (enExample) |
| WO (1) | WO2010124812A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2562721A (en) * | 2017-05-16 | 2018-11-28 | Fastbase Solutions Ltd | Kits, methods and their uses for detecting cell-cell interactions in a sample |
| WO2023244744A2 (en) * | 2022-06-15 | 2023-12-21 | Nonexomics, Inc. | Compositions and methods for treatment of cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019812D0 (en) | 1990-09-11 | 1990-10-24 | Scotgen Ltd | Novel antibodies for treatment and prevention of infection in animals and man |
| US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US20070042392A1 (en) * | 2000-02-03 | 2007-02-22 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| PT1309726E (pt) | 2000-03-30 | 2010-03-08 | Whitehead Biomedical Inst | Mediadores de interferência por rna específicos de sequência de rna |
| WO2004058153A2 (en) * | 2002-12-20 | 2004-07-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. |
| DE102005013846A1 (de) * | 2005-03-24 | 2006-10-05 | Ganymed Pharmaceuticals Ag | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
| US20070231822A1 (en) * | 2006-02-28 | 2007-10-04 | Michael Mitas | Methods for the detection and treatment of cancer |
| CN102308212A (zh) * | 2008-12-04 | 2012-01-04 | 加利福尼亚大学董事会 | 用于确定前列腺癌诊断和预后的材料和方法 |
-
2009
- 2009-04-29 EP EP09005931A patent/EP2249159A1/en not_active Withdrawn
-
2010
- 2010-04-22 WO PCT/EP2010/002490 patent/WO2010124812A2/en not_active Ceased
- 2010-04-22 US US13/266,368 patent/US20120070430A1/en not_active Abandoned
- 2010-04-22 JP JP2012507624A patent/JP2012525121A/ja active Pending
- 2010-04-22 AU AU2010243863A patent/AU2010243863A1/en not_active Abandoned
- 2010-04-22 EP EP10716294A patent/EP2425252A2/en not_active Withdrawn
- 2010-04-22 CA CA2760395A patent/CA2760395A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250199005A1 (en) | Depleting tumor-specific tregs | |
| JP2007537197A5 (enExample) | ||
| ES2583754T3 (es) | Productos génicos expresados de manera diferencial en tumores y utilización de los mismos | |
| JP2010047597A5 (enExample) | ||
| ES2664386T3 (es) | Identificación de antígenos asociados a tumor para el diagnóstico y la terapia | |
| JP2007506417A5 (enExample) | ||
| JP2008537546A5 (enExample) | ||
| JP2006516190A5 (enExample) | ||
| JP2010063458A5 (enExample) | ||
| CN105349618B (zh) | 三阴性乳腺癌标记物及其在诊断和治疗中的应用 | |
| JP2008508861A5 (enExample) | ||
| JP2009540852A5 (enExample) | ||
| AU2020322440A2 (en) | Compositions and methods of using C/EBP alpha saRNA | |
| JP2007526759A5 (enExample) | ||
| CN109709335B (zh) | 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用 | |
| JP2012525121A5 (enExample) | ||
| CN108003239A (zh) | 一种全人源抗egfr单链抗体及其应用 | |
| JP2009523004A5 (enExample) | ||
| CN110305963A (zh) | 一种食管癌分子标志物及其应用 | |
| CN110713544A (zh) | 融合基因plekha6-ntrk3及其在lch中的应用 | |
| JP2007077155A5 (enExample) | ||
| JP2006104212A5 (enExample) | ||
| US20160067314A1 (en) | Compositions and methods for inhibiting chemoresistance in cancer and improving response to therapy | |
| CN101161283B (zh) | CMTM1-v17的新应用及其拮抗剂 | |
| CN105331691B (zh) | Pzp基因在胆管癌诊断和治疗中的应用 |